| Perry J Depietro, DO | |
|
1614 South Blvd, Charlotte, NC 28203-4726 | |
| (704) 338-1268 | |
| Not Available |
| Full Name | Perry J Depietro |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Occupational Medicine |
| Location | 1614 South Blvd, Charlotte, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972621910 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083X0100X | Preventive Medicine - Occupational Medicine | 200100134 (North Carolina) | Primary |
| Entity Name | American Current Care Of North Carolina Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306015102 PECOS PAC ID: 8426196098 Enrollment ID: O20091119000309 |
News Archive
Watson Pharmaceuticals, Inc. and Natco Pharma Limited today confirmed an exclusive, U.S. development and license agreement, to develop and commercialize lenalidomide 5, 10, 15 and 25 mg tablets. The companies also confirmed that Natco has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its lenalidomide 5, 10, 15 and 25 mg product. Natco's lenalidomide tablets are generic versions of Celgene's Revlimid ® Tablets.
Today's state news includes Wyoming's worries about a Medicaid crunch, a surprising last minute solution to California's children health worries, the state's high insurance claims denial rates, and a windfall of stimulus grants to medical researchers in Massachusetts.
Meridian Bioscience, Inc. announced today that it has submitted a 510(k) application to the United States Food and Drug Administration for marketing clearance of its new, simple molecular diagnostic test, illumigene™ C. difficile. illumigene is a simplified new technology platform, based upon loop amplification (LAMP) that makes molecular diagnostic testing possible for any size laboratory.
CEA-Leti today announced the launch of the TARGET-PDT project designed to increase the effectiveness of photodynamic therapy for treating cancer by developing a novel nano carrier-based approach.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Perry J Depietro, DO 720 Cool Springs Blvd, Suite 300, Franklin, TN 37067-2626 Ph: (615) 778-4066 | Perry J Depietro, DO 1614 South Blvd, Charlotte, NC 28203-4726 Ph: (704) 338-1268 |
News Archive
Watson Pharmaceuticals, Inc. and Natco Pharma Limited today confirmed an exclusive, U.S. development and license agreement, to develop and commercialize lenalidomide 5, 10, 15 and 25 mg tablets. The companies also confirmed that Natco has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its lenalidomide 5, 10, 15 and 25 mg product. Natco's lenalidomide tablets are generic versions of Celgene's Revlimid ® Tablets.
Today's state news includes Wyoming's worries about a Medicaid crunch, a surprising last minute solution to California's children health worries, the state's high insurance claims denial rates, and a windfall of stimulus grants to medical researchers in Massachusetts.
Meridian Bioscience, Inc. announced today that it has submitted a 510(k) application to the United States Food and Drug Administration for marketing clearance of its new, simple molecular diagnostic test, illumigene™ C. difficile. illumigene is a simplified new technology platform, based upon loop amplification (LAMP) that makes molecular diagnostic testing possible for any size laboratory.
CEA-Leti today announced the launch of the TARGET-PDT project designed to increase the effectiveness of photodynamic therapy for treating cancer by developing a novel nano carrier-based approach.
› Verified 5 days ago
David Matthew Sullivan, MD Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Blythe Blvd, Charlotte, NC 28203 Phone: 704-355-2171 | |
James A. Watkins, M.D. Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 1601 Abbey Pl, Ste. 105, Charlotte, NC 28209 Phone: 704-512-5360 Fax: 704-512-5080 | |
Leigh Ann Barrett Holden, LPN Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 4221 Tuckaseegee Rd, Charlotte, NC 28208 Phone: 123-456-7890 | |
Dr. Keith James Baugh, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 9303 S Tryon St, Charlotte, NC 28273 Phone: 704-588-1265 Fax: 704-588-1286 | |
Lakisha Anderson Highe, AGNP Preventive Medicine Medicare: Medicare Enrolled Practice Location: 8800 N Tryon St, Charlotte, NC 28262 Phone: 704-863-6000 | |
Dr. John Nichols Beard, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 9303 S Tryon St, Charlotte, NC 28273 Phone: 704-588-1265 Fax: 704-588-1286 | |
Fabienne Ransom, D.O. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 646 Westinghouse Blvd, Charlotte, NC 28273 Phone: 615-778-4066 |